Recombinant PE-Labeled Human EGFRVIII Protein
Beta LifeScience
SKU/CAT #: BLK-02242P-100UG
Recombinant PE-Labeled Human EGFRVIII Protein
Beta LifeScience
SKU/CAT #: BLK-02242P-100UG
Our products are highly customizable to meet your specific needs. You can choose options such as endotoxin removal, liquid or lyophilized forms, preferred tags, and the desired functional sequence range for proteins. Submitting a written inquiry expedites the quoting process.
Product Overview
Description | Recombinant PE-Labeled Human EGFRVIII Protein is expressed from HEK293 with His tag and Avi tag at the C-Terminus.It contains Leu25-Ser378. |
Accession | NP_001333870.1 |
Target Symbol | EGFRVIII |
Synonyms | ErbB; EC 2.7.10; EC 2.7.10.1; EGFR; mENA; LEGFR; ERBB; ERBB1; HER1; PIG61; NISBD2 |
Species | Human |
Expression System | HEK293 |
Tag | C-His-Avi |
Expression Range | Leu25-Ser378 |
Mol. Weight | The protein has a predicted MW of 41.6 kDa. |
Form | Liquid |
Formulation | Supplied as 0.22um filtered solution in PBS (pH 7.4). |
Endotoxin | Less than 1EU per ug by the LAL method. |
Storage | Valid for 6 months from date of receipt when stored at -80°C.; Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles. |
Shipping | Shipped with dry ice. |
Gene Background | The epidermal growth factor receptor (EGFR) is overexpressed in a variety of human epithelial tumors, often as a consequence of gene amplification. Tumors with EGFR gene amplification frequently contain EGFR gene rearrangements, with the most common extracellular domain mutation being EGFRvIII. This mutation leads to a deletion of exons 2-7 of the EGFR gene and renders the mutant receptor incapable of binding any known ligand. |